Sun Pharma Industries receives Warning Letter for Halol facility
From USFDA
Sun Pharma Industries announced that it has received a Warning Letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.Powered by Capital Market - Live News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 19 2015 | 2:48 PM IST